Yahoo
BSE - Delayed Quote INR

Piramal Pharma Limited (PPLPHARMA.BO)

239.05 +8.45 (+3.66%)
At close: October 30 at 3:50:03 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name Title Pay Exercised Year Born
Ms. Nandini Ajay Piramal
Executive Chairperson -- -- 1980
Mr. Vivek Valsaraj
CFO & Executive Director -- -- 1973
Mr. Peter Daniel DeYoung
CEO of Piramal Global Pharma & Director -- -- 1978
Vinay Agarwal
Senior Vice President of Operations -- -- 1964
Mr. Gagan Borana
Head of Investor Relations & Sustainability -- -- --
Mr. Sandeep K. Rathod
General Counsel -- -- --
Mr. Maneesh Sharma
Company Secretary & Compliance Officer -- -- --
Prashanth M. S.
Vice President of Sales -- -- 1973
Ms. Puneet Rajput
Chief Human Resources Officer -- -- --
Mr. Debashish Chakravorty
Executive Vice President of India & UK Formulations -- -- 1967

Piramal Pharma Limited

Ananta Building
Piramal Corporate Park Opp. Fire Brigade Kamani Junction, LBS Marg, Kurla West
Mumbai, 400 070
India
91 22 3802 3000 https://www.piramalpharma.com
Sector: 
Healthcare
Full Time Employees: 
7,120

Description

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids' wellness, digestives, and women's health, as well as geriatric care. In addition, the company operates as a contract development and manufacturing organization, providing process development, scale-up, and GMP manufacturing services for vaccines and biologics. The company was incorporated in 2020 and is based in Mumbai, India.

Corporate Governance

Piramal Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 27, 2027 at 10:00 AM UTC

Piramal Pharma Limited Earnings Date

Recent Events

July 16, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: